hiv Clinical Trials and Research
Also known as: hiv infection, human immunodeficiency virus, aids, seropositive, hiv disease · ICD-10: B20
HIV (Human Immunodeficiency Virus) is a condition that weakens the immune system, making the body vulnerable to infections. Clinical trial research actively explores new treatments, prevention methods, and potential cures. Find a Trial helps patients search for active studies in this crucial area.
Common questions about hiv clinical trials
What are common eligibility criteria for HIV clinical trials?
Eligibility for HIV clinical trials often includes specific age ranges, HIV status, and overall health markers like CD4 count or viral load. Researchers also consider a participant's medical history and current medications. This ensures the study is safe and effective for participants, based on data from ClinicalTrials.gov.
What are the different phases of HIV clinical trials?
HIV clinical trials typically progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and dosage, and Phase 3 compares new interventions to existing ones. Phase 4 studies long-term effects after approval. This structured approach helps ensure new treatments are safe and beneficial, as detailed on ClinicalTrials.gov.
Do participants have to pay to join an HIV clinical trial?
Generally, participants do not pay to join HIV clinical trials, and study-related medical care is often provided at no cost. Some trials may also offer compensation for travel or time. Specific financial details are outlined in the informed consent process, according to information from ClinicalTrials.gov.
What are current research directions for HIV treatments?
Current HIV research focuses on developing long-acting antiretroviral therapies, new prevention strategies like PrEP, and therapeutic vaccines. Scientists are also exploring gene therapies and "shock and kill" approaches to target latent viral reservoirs, as reported by NIH RePORTER and ClinicalTrials.gov.
What types of interventions are studied in HIV clinical trials?
HIV clinical trials investigate various interventions, including new antiretroviral drugs, combination therapies, and different formulations like injectables or implants. Studies also explore vaccines, immune-based therapies, and strategies to reduce inflammation or address co-infections, according to ClinicalTrials.gov.
What biomarkers are important in HIV clinical trials?
Key biomarkers in HIV clinical trials include viral load (amount of virus in blood), CD4 cell count (immune cell health), and drug resistance mutations. Researchers also monitor markers of inflammation and immune activation to assess treatment efficacy and disease progression, based on data from ClinicalTrials.gov.
What are common reasons someone might be excluded from an HIV clinical trial?
Common exclusion criteria for HIV trials can include uncontrolled co-existing medical conditions, specific medication use that might interact with the study drug, or a history of severe allergic reactions. Pregnancy or breastfeeding are also often exclusion factors to ensure safety, as seen on ClinicalTrials.gov.
Are there clinical trials focused on HIV prevention?
Yes, many clinical trials are dedicated to HIV prevention. These studies investigate new forms of pre-exposure prophylaxis (PrEP), such as long-acting injectables or implants, and explore vaccine candidates. Behavioral interventions and microbicides are also areas of active research, according to ClinicalTrials.gov.
How to find a hiv trial that fits you
- Describe your hiv situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.